Hosts Jim Mazzo and John A. Hovanesian, MD, FACS, discuss the latest ophthalmic industry news and interview Sean Ianchulev, MD, MPH.

• Welcome to the Eyeluminaries podcast :01
• A review of the previous episode :23
• News and notes with John and Jim 1:31
• Alcon to acquire Aerie Pharmaceuticals 1:40
• Glaukos, iVeena enter licensing agreement for keratoconus treatment 5:20
• Lions Eye Institute to acquire SightLife 8:37
• Novaliq submits NDA for CyclASol for treatment of dry eye disease 11:37
• AbbVie, iSTAR enter alliance to support MINIject MIGS device 13:30
• Introduction of Sean Ianchulev 16:30
• The interview 18:37
• Impact on Google Glass 21:32
• What innovations are you proud of and what projects are you excited about? 26:20
• What advice do you have for new entrepreneurs? 33:04
• How do you balance your work life and your home life? 36:24
• Legends in the field of ophthalmology 38:07
• Give feedback at [email protected] 39:39
• A preview of the next episode of Eyeluminaries 39:54
• Thanks for listening 40:26

Sean Ianchulev, MD, MPH, is a Harvard-trained physician-scientist, a professor of ophthalmology and the head of innovation and technology at New York Eye and Ear Infirmary founder and chairman of Iantrek Inc and Eyenovia and serves as a board member for the American Society of Cataract and Refractive Surgery Foundation and AEYE Health.

John A. Hovanesian, MD, FACS, is a faculty member at the UCLA Jules Stein Eye Institute and in private practice at Harvard Eye Associates in Laguna Hills, California.

Jim Mazzo sits on numerous ophthalmic industry corporate boards and committees after serving in executive roles with Allergan, Avellino Labs, Carl Zeiss and AMO.

We’d love to hear from you! Send your comments/questions to [email protected]. Follow John Hovanesian on Twitter @DrHovanesian. You can find Dr. Ianchulev on LinkedIn: Sean Ianchulev, MD, MPH.

Disclosures: Hovanesian consults widely in the ophthalmic field. Mazzo reports being an adviser for Zeiss, Bain Capital, Avellino Labs, CVC Capital, Anivive Lifesciences; executive chairman of Neurotech, Preceyes BV and TearLab; and sits on the board of Crystilex, Lensgen, IanTech, Centricity Vision and Visus.